Form 4 Tracker
Bobak R. Azamian

Director, President/CEO and Board Chair · 6 filings · Latest: Sep 4, 2026

Tarsus Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TARS
Azamian Bobak R.—Mar 18, 2025
Proposed Sale
$46.287,131$330.1K—

← Previous

Page 2 of 2